Ronda Copher

Universidad San Carlos — PY

Medicine · Health Sciences

13h-index1.1kcitations102works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(19), Economic and Financial Impacts of Cancer(17), Cancer Treatment and Pharmacology(12), Epilepsy research and treatment(11), Chronic Myeloid Leukemia Treatments(11)

Publications102 total

Outcomes during BTKi treatment for chronic lymphocytic leukemia: Insights from remote therapeutic monitoring
Blood·2025Open Access
MSR100 The Importance of Assessment Design When Capturing Reasons for Therapeutic Change in Cancer Care
Value in Health·2024Open Access
Corrigendum to “Real-world clinical outcomes with enasidenib in relapsed or refractory acute myeloid leukemia” [Leuk. Res. (2022) 106946]
Leukemia Research·2024
Economic burden during remission and after relapse among older patients with newly diagnosed acute myeloid leukemia without hematopoietic stem cell transplant: A retrospective study using the SEER-Medicare database
Leukemia Research·2023· 4 cited
The implementation of value-based frameworks, clinical care pathways, and alternative payment models for cancer care in the United States
Journal of Managed Care & Specialty Pharmacy·2023· 2 citedOpen Access
Does Having a Grandchild Strengthen Intergenerational Solidarity? Financial, Instrumental and Emotional Support Exchanges in Taiwan
2023
Indirect Treatment Comparison of Oral Versus Injectable Azacitidine as Maintenance Therapy for Acute Myeloid Leukemia
Future Oncology·2022· 3 citedOpen Access
Economic burden in US patients with newly diagnosed acute myeloid leukemia receiving intensive induction chemotherapy
Future Oncology·2022· 6 citedOpen Access
Poster: AML-430 A Surveillance, Epidemiology, and End Results (SEER)-Medicare Analysis of the Economic Burden Among Elderly Patients With Acute Myeloid Leukemia (AML) Treated With Hypomethylating Agents (HMA)
Clinical Lymphoma Myeloma & Leukemia·2022
AML-430 A Surveillance, Epidemiology, and End Results (SEER)-Medicare Analysis of the Economic Burden Among Elderly Patients With Acute Myeloid Leukemia (AML) Treated With Hypomethylating Agents (HMA)
Clinical Lymphoma Myeloma & Leukemia·2022
Real-world clinical outcomes with enasidenib in relapsed or refractory acute myeloid leukemia
Leukemia Research·2022· 5 cited
The impact of remission duration on the long-term economic burden of acute myeloid leukemia among patients without hematopoietic stem cell transplant in the United States
Journal of Medical Economics·2022· 2 citedOpen Access
Treatment Patterns, Health Care Resource Utilization, and Cost in Patients with Myelofibrosis in the United States
The Oncologist·2022· 13 citedOpen Access
Healthcare Resource Utilization and Costs in US Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Intensive Induction Chemotherapy
Blood·2021
Treatment Patterns and Economic Burden Among Elderly Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents: A SEER-Medicare Analysis
Blood·2021
Challenges and opportunities of alternative payment models for physicians/quality officers in community/academic oncology practice sites via a national prospective survey.
Journal of Clinical Oncology·2021
CML-479: Systematic Literature Review of Treatment Patterns, Long-Term Efficacy, and Safety of Dasatinib Therapy for Patients with Chronic Myeloid Leukemia
Clinical Lymphoma Myeloma & Leukemia·2021· 1 cited
Poster: CML-479: Systematic Literature Review of Treatment Patterns, Long-Term Efficacy, and Safety of Dasatinib Therapy for Patients with Chronic Myeloid Leukemia
Clinical Lymphoma Myeloma & Leukemia·2021
PCN153 Physicians’ Perceptions and Use of IDH1/2 Mutational Testing and Treatment Selection among Patients with Relapsed or Refractory Acute Myeloid Leukemia in Routine Clinical Practice
Value in Health·2021
PCN51 Annual Healthcare Resource Utilization and Costs in U.S. Patients Diagnosed with Relapsed Acute Myeloid Leukemia
Value in Health·2021
page 1 of 6Next →

Frequent Co-authors

David Huggar(9), Russell L. Knoth(6), Ashley Tabah(6), Joyce A. Cramer(5), Michael S. Broder(5), Jonathan Kish(5), Ali McBride(5), Zhixiao J. Wang(4), Eunice Chang(4), Annette Powers(4), Genevieve Meier(4), Arianna Kee(4), Aaron T. Gerds(4), Thomas W. LeBlanc(4), Dasha Cherepanov(3), Marco DiBonaventura(3), Enrique Basurto(3), Claudio Faria(3), Paul Buzinec(3), Julie Huynh(3)